Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to <18-year-old children and adolescents at risk of influenza-related complications
Article in International Journal of Infectious Diseases (June 2016)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Flucelvax (Optaflu) for seasonal influenza
Article in Expert Review of Vaccines (May 2015)